Best Fit Profiles
- clinician-guided stone prevention protocols
Acid-base and kidney stone risk support
Potassium Citrate
Established clinical use for urinary citrate support and stone-risk reduction in selected settings.
Evidence Level A
Evidence and Risk Labels
Evidence A/B/C reflects research maturity, and risk levels reflect monitoring needs. These labels support comparison, not diagnosis or treatment decisions.
See full scoring guideClinical Snapshot
- Effect Size
- Meaningful reduction in kidney stone recurrence risk in indicated populations
- Safety
- Needs Monitoring
Requires clinical oversight in renal disease and with potassium-sensitive medications.
Research Dosing
This reflects common ranges and protocols used in published studies, not personal medical advice.
- Typical Daily Dose
- 10-30 mEq (individualized)
- Timing
- Divided doses with meals
- Protocol Duration in Studies
- Longitudinal with laboratory and urinary monitoring
Dose should be guided by urinary chemistry and renal function context.